Sino Medical Sciences Technology, Inc.

78
Buy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003NY2
CNY
21.86
-0.33 (-1.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
519.00
455.00
341.00
192.00
192.00
324.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
519.00
455.00
341.00
192.00
192.00
324.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
200.00
162.00
145.00
141.00
114.00
98.00
Operating Expenses
5.00
5.00
3.00
2.00
2.00
0.00
General and Administration Expenses
143.00
143.00
126.00
131.00
118.00
127.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
468.00
483.00
411.00
400.00
349.00
313.00
Operating Profit (PBDIT) excl Other Income
51.00
-28.00
-70.00
-207.00
-156.00
11.00
Other Income
25.00
33.00
15.00
8.00
7.00
19.00
Operating Profit (PBDIT)
167.00
91.00
28.00
-126.00
-77.00
75.00
Interest
5.00
5.00
3.00
2.00
2.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
93.00
102.00
87.00
87.00
80.00
46.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
68.00
-17.00
-62.00
-216.00
-160.00
28.00
Provision for Tax
20.00
-13.00
-24.00
-48.00
-31.00
6.00
Profit After Tax
47.00
1.00
-39.00
-162.00
-130.00
22.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.11
0.00
-0.10
-0.40
-0.32
0.05
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 14.15% vs 33.31% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 283.33% vs 59.95% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -9.75% vs 48.41% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 3,057.07% vs 103.78% in Dec 2024

Compare Profit and Loss Results of Sino Medical Sciences Technology, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
519.00
0
519.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
519.00
0
519.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
200.00
0
200.00
0%
Operating Expenses
5.00
0
5.00
0%
General and Administration Expenses
143.00
0
143.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
468.00
0
468.00
0%
Operating Profit (PBDIT) excl Other Income
51.00
0.00
51.00
0%
Other Income
25.00
0
25.00
0%
Operating Profit (PBDIT)
167.00
0
167.00
0%
Interest
5.00
0
5.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
93.00
0
93.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
68.00
0
68.00
0%
Provision for Tax
20.00
0
20.00
0%
Profit After Tax
47.00
0
47.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.114
0
0.11
0%
Profit And Loss - Net Sales
Net Sales 519.48 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 14.15% vs 33.31% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.46 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 283.33% vs 59.95% in Dec 2024

Profit And Loss - Interest
Interest 5.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -9.75% vs 48.41% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 47.29 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 3,057.07% vs 103.78% in Dec 2024